Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Inventory: 2020-2024

Historic Inventory for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $8.6 million.

  • Burning Rock Biotech's Inventory fell 19.19% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year decrease of 19.19%. This contributed to the annual value of $8.6 million for FY2024, which is 11.74% down from last year.
  • Per Burning Rock Biotech's latest filing, its Inventory stood at $8.6 million for FY2024, which was down 11.74% from $9.7 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Inventory registered a high of $19.3 million during FY2021, and its lowest value of $8.6 million during FY2024.
  • Its 3-year average for Inventory is $12.4 million, with a median of $9.7 million in 2023.
  • As far as peak fluctuations go, Burning Rock Biotech's Inventory skyrocketed by 85.47% in 2021, and later tumbled by 48.55% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Inventory (MRY) stood at $10.4 million in 2020, then surged by 85.47% to $19.3 million in 2021, then decreased by 2.28% to $18.9 million in 2022, then plummeted by 48.55% to $9.7 million in 2023, then dropped by 11.74% to $8.6 million in 2024.
  • Its last three reported values are $8.6 million in FY2024, $9.7 million for FY2023, and $18.9 million during FY2022.